UnityPoint Health-St. Luke's in Cedar Rapids, Iowa, has so far enrolled four out of around 20 planned patients in a five-year international clinical trial of LivaNova's chronic heart failure therapy Vitaria System. Amy Schweer, clinical research coordinator at the site's Heart and Vascular Institute, said "everything has been positive" since the trial started in 2018.
LivaNova device trial seeing positive results at Iowa site
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.